Johnson & Johnson (NYSE:JNJ) has raised its offer to settle thousands of lawsuits alleging its baby powder caused ... the sources added. Settlement talks are ongoing. J&J (JNJ) maintains that ...

The ruling means J&J will have to fight roughly 60,000 claims brought by women who say the company’s hallmark baby powder caused ... company increased its settlement offer, more claimants ...

A federal judge in Houston has rejected the third attempt by Johnson & Johnson’s (J ... settlement was intended to resolve nearly all claims that the company’s talc products such as baby ...

A US bankruptcy judge on Monday rejected Johnson & Johnson’s US$10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third ...

which has been battling class-action litigation claiming that its talc-based products like Johnson’s Baby Powder have caused cancer and has put a $6.5 billion settlement offer on the table ...

In a statement, J&J said Baby Powder was one of 100 products it had decided to discontinue after a review of its product range sparked by the coronavirus pandemic. The Baby Powder decision was ...

The de-escalation drew an immediate thumbs up from Wall Street, as equity index futures jumped by nearly 2% on the resumption of trading on Tuesday evening.

A U.S. bankruptcy court judge has denied Johnson & Johnson's settlement plan related ... the third bankruptcy case for a J&J company as it relates to the baby powder issue. Advertisement Article ...

A U.S. bankruptcy court judge has denied Johnson & Johnson's settlement plan related to baby powder containing talc, providing another setback in the company's efforts to resolve the matter.